Early-goal-directed therapy and protocolised treatment in septic shock

Size: px
Start display at page:

Download "Early-goal-directed therapy and protocolised treatment in septic shock"

Transcription

1 CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) ! The Intensive Care Society 2014 Reprints and permissions: sagepub.co.uk/ journalspermissions.nav DOI: / jics.sagepub.com Use of an Early-Goal-Directed therapy protocol did not improve outcome in patients with septic shock in comparison to a standard treatment protocol, or usual care based on physician judgement. Level of Evidence: 1B Appraised by: G Evetts, K Birch Citation: The ProCESS Investigators. A randomised trial of protocol-based care for early septic shock. N Engl J Med 2014;370: Lead author: Derek C Angus, angusdc@upmc.edu Three-part clinical question: Patients: Patients with a diagnosis of septic shock refractory to initial fluid resuscitation of 1000 ml. Intervention: Patients were randomised to one of three groups: (a) early-goal-directed therapy (EGDT) (b) Standard protocol therapy (c) Usual care as directed by bedside physician. Outcomes: Primary outcome was 60 days inhospital mortality. Secondary outcomes included mortality at 90 days and 1 year, a requirement for organ support, length of stay in intensive care and hospital, discharge disposition and any serious adverse events. The study design: Prospective, randomised, multicentre trial recruiting from 31 Emergency Departments (EDs) of tertiary teaching hospitals with > 40,000 yearly ED visits, who adhere to surviving sepsis campaign guidelines, use serum lactate as a screen for cryptogenic septic shock but do not routinely use central venous oxygen saturation (ScvO 2 ) catheters or have a septic shock resuscitation bundle. Statistical analysis was conducted before unblinding. The study patients: Inclusion criteria: Patients >18 years of age admitted to ED with a diagnosis of sepsis according to the physician with 52 systemic inflammatory response syndrome (SIRS) criteria and refractory hypotension (systolic <90) or lactate 54 despite 1000 ml fluid challenge in 30 min. All patients were enrolled within 2 h of detection of shock and within 12 h of admission. Exclusion criteria: Patients with acute coronary syndrome, pulmonary oedema, status asthmaticus, major cardiac arrhythmia, gastrointestinal haemorrhage, seizures, drug overdose, burns, trauma, pregnancy, inter-hospital transfer, low CD4 count, and when treatment was considered futile. Study groups: Each protocol was followed for 6 h post randomisation. Thereafter, care was left to the discretion of the responsible team. EGDT protocol group (439 patients): central venous saturation oximetry probe to target ScvO 2 of 70% with fluid boluses, haematocrit optimization to 0.3 or inotropic agents (Figure 1). Standard protocol group (446 patients): peripheral access only, unless vasoactive agents were required or there was difficulty in obtaining intravenous access. Each protocol was followed for the first 6 h after randomisation (Figure 2). Both the protocol groups were cared for by the same trained and dedicated physician-led team. Adherence to study protocols was monitored by external study staff using a flow chart examining physiological goals and actions in attempt to achieve them. Usual care group (456 patients): This was left to the discretion of a non-study clinician. Results- see tables overleaf. EBM Questions 1. Do the methods allow accurate testing of the hypothesis? Yes. This was a multi-centre, randomized, comparison of protocols against a nonstandardised approach. The same team provided care to the patients randomised to the protocolised care arms, but a separate non-study team provided care to the usual care group in order to minimise any operator bias. Study physicians could not be blinded, but data analysis was performed by blinded study personnel. Adherence to protocols was monitored by study staff using an adherence flowchart for each protocol arm. 2. Do the statistical tests correctly test the results to allow differentiation of statistically significant results? Yes. Data were analysed on an intention-to-treat principle. The investigators tested

2 Evetts and Birch 165 Table 1. Selected outcomes of the three groups. Outcome EGDT Standard therapy Usual care P Mortality 60 days 92/439 (21%) 81/446 (18.2%) 86/456 (18.9%) days 129/405 (31.9%) 128/415 (30.8%) 139/412 (33.7%).66 New organ failure, 1 week Cardiovascular 269/439(61.3%) 284/446 (63.7%) 256/456 (56.1%).06 Respiratory 165/434 (38%) 161/441 (36.5%) 146/451 (32.4%).19 Renal 12/382 (3.1%) 24/399 (6.0%) 11/397 (2.8%).04 Use of hospital resources ICU admission 401 (91.3%) 381 (85.4%) 393 (86.2%).01 ICU length of stay (days) Hospital stay (days) Table 2. Main intervention frequency in the three groups. Interventions EGDT standard therapy Usual care P Care process 0 72 h Intravenous fluids (ml) <.0001 Vasopressor use 265 (6.4%) 273 (61.2%) 245 (53.7).05 Dobutamine use 41 (9.3%) 11 (2.5%) 13 (2.9) <.0001 Blood transfusion 120 (27.3%) 107 (24%) 102 (22.4).22 Ventilation 159 (36.2%) 152 (34.1) 135 (29.6%).10 Table 3. Fluid resuscitation volumes at various time points in the study (mls). EGDT Standard therapy Usual care P Pre-randomisation h < h h <.0001 Table 4. Average ph of subjects at different time points in each study group. EGDT standard therapy Usual care P Pre-randomisation h h h h sequentially whether protocol-based resuscitation (EGDT or standard-based therapy) was superior to usual care, and then whether protocol-based EGDT was superior to protocol-based standard therapy. Power calculation based upon 80% to detect a mortality reduction of 6 7% gave a sample size of 1950 patients. This assumed a mortality of 30 46% in the usual care group based on the similar study by Rivers et al. 1 However, analysis before 1300 patients showed a lower than expected mortality of 20% which was also consistent with another study. 2 Recalculation gave a

3 166 Journal of the Intensive Care Society 16(2) Figure 1. Protocol for early goal-directed therapy (EGDT). IV: intravenous; CVP: central venous pressure; ScvO 2 : central venous oxygen saturations; HCT: haematocrit; PRBCs: packed red blood cells. sample size of 1350 for the same power. Primary outcome of 60-day mortality was tested using Fisher s exact test. In case of test site variability, secondary analysis included a linear mixed model, which allowed for any effect of study site. For all other secondary outcomes, Fisher s exact test was used for categorical outcomes and analysis of variance for continuous variables. Cumulative Kaplan-Meier mortality curves to display between-group differences were constructed. Breslow-Day tests assessed interactions between treatment assignment and subgroups such as age, sex, infective source, lactate levels, etc. Subgroup analysis based on Acute Physiology and Chronic Health Evaluation (APACHE) II score, baseline serum lactate levels and time from shock detection to randomization was also performed using logistical regression to test for correlation. 3. Are the conclusions valid in light of the results? Yes. Baseline characteristics between the groups were not significantly different in terms of demographics, source of sepsis, APACHE II score, serum lactate, or time to randomization. Adherence to protocols was high, with only 11.9% and 4.4% patients being non-adherent in the EGDT and standard-therapy groups, respectively. Treatment in terms of intravenous fluid volume, vasoactive drug usage and blood transfusion was not significantly different in the 6 72 h period. Use of antibiotics, glucocorticoids, and activated protein C was also not significant between the groups. However, it is worth noting that at 6 h the average ph values in the protocolbased groups were significantly lower than the usual care group at 7.1 and 7.4, respectively (Table 4). This could imply increased severity of

4 Evetts and Birch 167 Figure 2. Protocol for standard care. IVF: intravenous fluids; HCT: haematocrit; SBP: systolic blood pressure; SI: shock index (heart rate/systolic blood pressure); CVP: central venous pressure; ScvO 2 : central venous oxygen saturations; MAP: mean arterial pressure. sepsis in those groups. This theory might be supported by the fact that significantly more patients in the EGDT group were admitted to an intensive care unit (Table 1). 4. Did results get omitted and why? Yes. Ten patients withdrew their consent from the study, leaving 1341 patients in the analysis. 5. Did the author suggest any further areas for research? No. However, the authors do comment on the study s inability to examine what aspects of the very early stages of a patient s care may have on outcomes in sepsis. 6. Did they make recommendations based on the results and were they appropriate? No. No specific recommendations were made, but the authors declared that if patients with sepsis are identified early and received antibiotics in addition to other non-resuscitative aspects of care promptly, then there was no advantage in using a protocol-based resuscitation using central venous monitoring. 7. Is the study relevant to my clinical practice? Yes. The patients in the study are fully representative of UK patients with septic shock. EGDT using ScvO 2 has been part of fluid resuscitation in sepsis along with other patient cohorts for over 10 years, based on papers such as the Rivers study, 1 and Shoemaker. 3 The surviving sepsis campaign guidelines recommended use of ScvO 2, and thus it is considered best practice. This paper calls in to question the positive impact this has on patient outcome. 8. What level of evidence does the study represent? 1B. The study design and testing of adherence to study protocol, together with correct and interim power analysis make this a good quality study. 9. What grade of recommendation can I make on this result alone? A 10. What grade of recommendation can I make when this study is considered along with other available evidence? A. The recent ARISE trial 4 of similar design and quality yielded similar findings. The early study by Rivers et al. 1 had a higher mortality rate, was single-centred and had other possible confounding issues. The ProMISe trial, 5 a third trial of this nature will supply further evidence on the use of EGDT for sepsis.

5 168 Journal of the Intensive Care Society 16(2) 11. Should I change my practice because of these results? No. Both ProCESS, and ARISE showed overall mortality rates to be substantially lower than in the original Rivers study. This is possibly due to the surviving sepsis campaign generating increased awareness, diagnosis and early treatment of septic shock with appropriate antibiotics and fluid resuscitation. This would suggest that the early part of EGDT is the important component, and that current day standard accepted care of sepsis gave no worse outcome than goal-directed therapy. The surviving sepsis campaign intends to issue a statement based on the results of the three trials after they are published. 12. Should I audit my practice because of these results? Possibly. Central venous catheters (CVC) are associated with a degree of morbidity and therefore their use must be justified. Sole use of CVCs for monitoring ScvO 2 could therefore be considered unnecessary and not best practice. References 1. Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl JMedi 2001; 345: Jones AE, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010; 303: Shoemaker WC, et al. Sequence of physiologic patterns in surgical septic shock. Crit Care Med 1993; 21: The ARISE Investigators. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371(16): Power GS, et al. The protocolised management in sepsis (ProMISe) trial statistical analysis plan. Crit Care Resusc 2013; 15: Appraised by: George E Evetts MRCP FRCA, Speciality Trainee year 6, Anaesthesia & Intensive Care, Imperial College School of Anaesthsia, London, UK george.evetts@gmail.com Kristina Birch MRCP FRCA FFICM, Consultant in Anaesthesia and Intensive Care Medicine, North Bristol NHS Trust, Bristol, UK

Early Goal-Directed Therapy

Early Goal-Directed Therapy Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The

More information

Methodological co-investigators

Methodological co-investigators Protocolised Management In Sepsis: A multicentre randomised controlled trial of the clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock Methodological

More information

Fluid balance and clinically relevant outcomes

Fluid balance and clinically relevant outcomes Fluid balance and clinically relevant outcomes Rui Moreno, MD, PhD, Professor UCINC, Hospital de São José Centro Hospitalar de Lisboa Central, E.P.E. INSULT PRIMARY MODS SIRS SECONDARY MODS OUTCOME RECOVERY

More information

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us? Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us? Mitchell M. Levy MD, FCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care Warren Alpert Medical School

More information

Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia

Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia Early goal-directed therapy in septic shock 2001 Proof-of-concept EGDT trial published NEJM 16%

More information

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available

More information

Nothing to disclose 9/25/2017

Nothing to disclose 9/25/2017 Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain

More information

9/25/2017. Nothing to disclose

9/25/2017. Nothing to disclose Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain

More information

Updates in Sepsis 2017

Updates in Sepsis 2017 Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials

More information

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts, Sepsis Management and Hemodynamics Javier Perez-Fernandez, M.D., F.C.C.P. Medical Director Critical Care Services, Baptist t Hospital of Miamii Medical Director Pulmonary Services, West Kendall Baptist

More information

The ProCESS Investigators* ABSTRACT

The ProCESS Investigators* ABSTRACT The new england journal of medicine established in 1812 may 1, 2014 vol. 370 no. 18 A Randomized Trial of Protocol-Based Care for Early Septic Shock The ProCESS Investigators* ABSTRACT Background In a

More information

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Surviving Sepsis Campaign Guidelines 2012 & Update for 2015 David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Louis Be appropriately aggressive the longer one delays aggressive metabolic

More information

Sepsis Management Update 2014

Sepsis Management Update 2014 Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma

More information

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL COLLEGE NOVEMBER 10 TH 2017 TEXAS SCCM SYMPOSIUM Disclosures

More information

NIH Public Access Author Manuscript N Engl J Med. Author manuscript; available in PMC 2014 November 01.

NIH Public Access Author Manuscript N Engl J Med. Author manuscript; available in PMC 2014 November 01. NIH Public Access Author Manuscript Published in final edited form as: N Engl J Med. 2014 May 1; 370(18): 1683 1693. doi:10.1056/nejmoa1401602. A Randomized Trial of Protocol-Based Care for Early Septic

More information

Red Cell Transfusion triggers: A moving target When, who, and how much?

Red Cell Transfusion triggers: A moving target When, who, and how much? Red Cell Transfusion triggers: A moving target When, who, and how much? Tim Walsh Professor of Critical Care, Edinburgh University A transfusion threshold of 70 g/l or below, with a target Hb range of

More information

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Evidence-Based. Management of Severe Sepsis. What is the BP Target? Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco

More information

Updates in Emergency Department Management of Sepsis

Updates in Emergency Department Management of Sepsis Resident Journal Review Updates in Emergency Department Management of Sepsis Authors: Eli Brown, MD; Allison Regan, MD; Kaycie Corburn, MD; Jacqueline Shibata, MD Edited by: Jay Khadpe, MD FAAEM; Michael

More information

Staging Sepsis for the Emergency Department: Physician

Staging Sepsis for the Emergency Department: Physician Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected

More information

No conflicts of interest to disclose

No conflicts of interest to disclose No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,

More information

EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer

EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer EARLY GOAL DIRECTED THERAPY : Etat des lieux en 2017 Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles Past-President European

More information

UTILITY of ScvO 2 and LACTATE

UTILITY of ScvO 2 and LACTATE UTILITY of ScvO 2 and LACTATE Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland THIS TRIP SPONSORED AND PAID FOR BY STRUCTURE Physiology -

More information

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis

More information

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated

More information

Sepsis Management: Past, Present, and Future

Sepsis Management: Past, Present, and Future Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe

More information

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,

More information

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures Sepsis Update: Focus on Early Recognition and Intervention Jessie Roske, MD October 2017 Disclosures I have no actual or potential conflict of interest in relation to this program/presentation. I will

More information

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care

More information

towards early goal directed therapy

towards early goal directed therapy Paediatric Septic Shock- towards early goal directed therapy Elliot Long Paediatric Acute Care 2011 Conference Outline Emergency Department Rivers Protocol (EGDT) ACCM Sepsis Protocol Evidence Barriers

More information

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire Diagnosis and Management of Sepsis and Septic Shock Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire Financial: none Disclosures Objectives: Identify physiologic principles of septic

More information

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017 INTENSIVE CARE MEDICINE CPD EVENING Dr Alastair Morgan Wednesday 13 th September 2017 WHAT IS NEW IN ICU? (RELEVANT TO ANAESTHETISTS) Not much! SURVIVING SEPSIS How many deaths in England were thought

More information

Exclusion Criteria 1. Operator or supervisor feels specific intra- procedural laryngoscopy device will be required.

Exclusion Criteria 1. Operator or supervisor feels specific intra- procedural laryngoscopy device will be required. FELLOW Study Data Analysis Plan Direct Laryngoscopy vs Video Laryngoscopy Background Respiratory failure requiring endotracheal intubation occurs in as many as 40% of critically ill patients. Procedural

More information

Diagnosis and Management of Sepsis. Disclosures

Diagnosis and Management of Sepsis. Disclosures Diagnosis and Management of Sepsis David Shimabukuro, MDCM Medical Director, 13 ICU Physician Lead, UCSF Sepsis Bundle Compliance and Mortality Reduction I have no disclosures Disclosures 1 The following

More information

OHSU. Update in Sepsis

OHSU. Update in Sepsis Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin

More information

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust The Septic Patient Dr Arunraj Navaratnarajah Renal SpR Imperial College NHS Healthcare Trust Objectives of this session Define SIRS / sepsis / severe sepsis / septic shock Early recognition of Sepsis The

More information

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING Christopher Hunter, MD, PhD, FACEP Director, Health Services Department Associate Medical Director, Orange County EMS System Medical Director, Orlando Health

More information

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program Sepsis Story At Intermountain Healthcare 2004-2012 Intensive Medicine Clinical Program The International Surviving Sepsis Campaign Was Organized In 2002 During The ESICM International Meeting In Barcelona,

More information

Goal-directed vs Flow-guidedresponsive

Goal-directed vs Flow-guidedresponsive Goal-directed vs Flow-guidedresponsive therapy S Magder Department of Critical Care, McGill University Health Centre Flow-directed vs goal directed strategy for management of hemodynamics S Magder Curr

More information

Facilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Care Unit (FELLOW)

Facilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Care Unit (FELLOW) Facilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Data Analysis Plan: Apneic Oxygenation vs. No Apneic Oxygenation Background Critically ill patients

More information

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health What the ED clinician needs to know about SEPSIS - 3 Anna Morgan Consultant EM Barts Health Aims: (1) To review the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (2)

More information

Sepsis. Reliability- can we achieve Dr Ron Daniels

Sepsis. Reliability- can we achieve Dr Ron Daniels Sepsis. Reliability- can we achieve it? @SepsisUK Dr Ron Daniels Chief Executive, Global Sepsis Alliance Fellow: NHS Improvement Faculty Chief Executive: United Kingdom Sepsis Trust & Chair, UK SSC RRAILS

More information

Inflammatory Statements

Inflammatory Statements Inflammatory Statements Using ETCO 2 Analysis in Sepsis Syndromes George A. Ralls M.D. Orange County EMS System Sepsis Sepsis Over 750,000 cases annually Expected growth of 1.5% per year Over 215,000 deaths

More information

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of

More information

Troubleshooting Audio

Troubleshooting Audio Welcome! Audio for this event is available via ReadyTalk Internet Streaming. No telephone line is required. Computer speakers or headphones are necessary to listen to streaming audio. Limited dial-in lines

More information

MAKING SENSE OF IT ALL AUGUST 17

MAKING SENSE OF IT ALL AUGUST 17 MAKING SENSE OF IT ALL AUGUST 17 @SepsisUK Dr Ron Daniels B.E.M. CEO, UK Sepsis Trust CEO, Global Sepsis Alliance Special Adviser to WHO SCALE AND BURDEN @sepsisuk Dr Ron Daniels B.E.M. CEO, UK Sepsis

More information

Sepsis: Identification and Management in an Acute Care Setting

Sepsis: Identification and Management in an Acute Care Setting Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES

More information

Year in Review 2014: Critical Care Medicine

Year in Review 2014: Critical Care Medicine Disclosures Year in Review 2014: Critical Care Medicine I receive laboratory support from CytoVale Diagnostics for research on early sepsis diagnostics Eric J. Seeley, M.D., F.C.C.P. Assistant Professor

More information

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London IV fluid administration in sepsis Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London The talk What is septic shock? What are the recommendations? What is the evidence? Do we follow

More information

Advancements in Sepsis

Advancements in Sepsis Objectives Advancements in Sepsis Brian Gilbert, PharmD PGY-1 Pharmacy Resident Jackson Memorial Hospital 3/13/2016 www.fshp.org Pharmacist objectives Review recent updates in resuscitation strategies

More information

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS R. Phillip Dellinger MD, MSc, MCCM Professor and Chair of Medicine Cooper Medical School of Rowan University Chief of Medicine Cooper University Hospital

More information

BC Sepsis Network Emergency Department Sepsis Guidelines

BC Sepsis Network Emergency Department Sepsis Guidelines The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to

More information

Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016

Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016 National Clinical Guideline Centre Consultation Sepsis Sepsis: the recognition, diagnosis and management of sepsis NICE guideline Appendices I-O January 2016 Draft for consultation Commissioned

More information

Sepsis: What Is It Really?

Sepsis: What Is It Really? Sepsis: What Is It Really? Steven D. Burdette, MD, FIDSA, FACP Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship for Premier Health and Miami

More information

Managing Patients with Sepsis

Managing Patients with Sepsis Managing Patients with Sepsis Diagnosis; Initial Resuscitation; ARRT Initiation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum

More information

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis What works in sepsis Eric Schmidt, MD Denver Health Medical Center University of Colorado School of Medicine Topics Understanding and implemen@ng early goal directed therapy (EGDT) Ac@vated Protein C should

More information

Sepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti

Sepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti Sepsis and Hemodynamic Support in 2017 September 15, 2017 Carleen Risaliti Objectives Review fluid resuscitation guidelines in septic shock Discuss volume assessment v. fluid responsiveness Evaluate pros

More information

Where did it all begin?

Where did it all begin? EXPLORE Healthcare Summit Sepsis: Can We Finally Just Relax on the SOFA? Mark Keuchel, D.O. Background: 1. Sepsis is a wide-spectrum disease process that remains poorly understood 2. Early-goal directed

More information

Sepsis. From EMS to ER to ICU. What we need to be doing

Sepsis. From EMS to ER to ICU. What we need to be doing Sepsis From EMS to ER to ICU What we need to be doing NEHAL BHATT, MD ATHENS PULMONARY, CRITICAL CARE AND SLEEP Objectives 1. Define the changes to the definition of Sepsis 2. Describe the assessment,

More information

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program Sepsis 3 & Early Identification David Carlbom, MD Medical Director, HMC Sepsis Program Disclosures I have no relevant financial relationships with a commercial interest and will not discuss off-label use

More information

Trial of early, goal-directed resuscitation for septic shock

Trial of early, goal-directed resuscitation for septic shock Washington University School of Medicine Digital Commons@Becker Peer-Reviewed Publications Division of Emergency Medicine/Emergency Care Research Section 3-2015 Trial of early, goal-directed resuscitation

More information

Actualités de la prise en charge hémodynamique initiale Daniel De Backer

Actualités de la prise en charge hémodynamique initiale Daniel De Backer Actualités de la prise en charge hémodynamique initiale Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles Past- President European

More information

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018 Tailored Volume Resuscitation in the Critically Ill is Achievable Heath E Latham, MD Associate Professor Fellowship Program Director Pulmonary and Critical Care Objectives Describe the goal of resuscitation

More information

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa The syndrome formerly known as Severe Sepsis James Rooks MD Coordinator of critical care education OU College of Medicine, Tulsa Disclosures I have no actual or practical conflicts of interest in relation

More information

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM 1 Surviving Sepsis Brian Woodcock MBChB MRCP FRCA FCCM 2 Disclosures No conflicts of interest 3 Sepsis Principles of management of septic shock in the operating room "Surviving Sepsis" guidelines 4 Add-on

More information

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare

More information

SEPSIS SYNDROME

SEPSIS SYNDROME INTRODUCTION Sepsis has been defined as a life threatening condition that arises when the body s response to an infection injures its own tissues and organs. Sepsis may lead to shock, multiple organ failure

More information

The changing face of

The changing face of The changing face of sepsis. @SepsisUK Dr Ron Daniels B.E.M. CEO, UK Sepsis Trust CEO, Global Sepsis Alliance Special Adviser (maternal sepsis) to WHO Breast cancer Cognitive impairment Mild 3.8 7.1

More information

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%

More information

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated Update on Surviving Sepsis 2008 Objectives Epidemiology of Sepsis Definition of Sepsis and Septic Shock Review Guidelines for Resuscitation Dx: Lactate, t cultures, SVO2 Tx: EGDT, timing/choice of abx,

More information

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. SEPSIS: IT ALL BEGINS WITH INFECTION Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. Worth 1 2 3 OBJECTIVES Review the new Sepsis 3 definitions of sepsis

More information

Fluid balance in Critical Care

Fluid balance in Critical Care Fluid balance in Critical Care By Dr HP Shum Nephrologist and Critical Care Physician Department of Intensive Care, PYNEH Fluid therapy is a critical aspect of initial acute resuscitation in critically

More information

Presented by: Indah Dwi Pratiwi

Presented by: Indah Dwi Pratiwi Presented by: Indah Dwi Pratiwi Normal Fluid Requirements Resuscitation Fluids Goals of Resuscitation Maintain normal body temperature In most cases, elevate the feet and legs above the level of the heart

More information

Sepsis and septic shock: can we win the battle against this hidden crisis?

Sepsis and septic shock: can we win the battle against this hidden crisis? REVIEW ARTICLE Sepsis and septic shock: can we win the battle against this hidden crisis? V.G. Dassanayake Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka Key words : Sepsis;

More information

A Critical Review of Early Goal Directed Therapy and Government Endorsement

A Critical Review of Early Goal Directed Therapy and Government Endorsement A Critical Review of Early Goal Directed Therapy and Government Endorsement Charles Natanson M.D. Critical Care Medicine Department Clinical Center National Institutes of Health Clinical Center None Conflicts

More information

SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP

SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP OBJECTIVES Arise, ProMISE, ProCESS Key points in sepsis management The CMS sepsis core measure COST OF SEPSIS CARE IN US Most

More information

From Bench to Bedside: Reducing Sepsis Mortality

From Bench to Bedside: Reducing Sepsis Mortality Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/from-bench-to-bedside-reducing-sepsismortality/4009/

More information

Transfusion for the sickest ICU patients: Are there unanswered questions?

Transfusion for the sickest ICU patients: Are there unanswered questions? Transfusion for the sickest ICU patients: Are there unanswered questions? Tim Walsh Professor of Critical Care Edinburgh University None Conflict of Interest Guidelines on the management of anaemia and

More information

PFIZER INC. Study Center(s): A total of 6 centers took part in the study, including 2 in France and 4 in the United States.

PFIZER INC. Study Center(s): A total of 6 centers took part in the study, including 2 in France and 4 in the United States. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.

More information

SURVIVING SEPSIS: Early Management Saves Lives

SURVIVING SEPSIS: Early Management Saves Lives SURVIVING SEPSIS: Early Management Saves Lives Pat Posa RN, BSN, MSA System Performance Improvement Leader St. Joseph Mercy Health System Ann Arbor, MI Patricia.posa@stjoeshealth.org Objectives a. Understand

More information

[No conflicts of interest]

[No conflicts of interest] [No conflicts of interest] Patients and staff at: Available evidence pre-calories Three meta-analyses: Gramlich L et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes

More information

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL) PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to

More information

Admissions with severe sepsis in adult, general critical care units in England, Wales and Northern Ireland

Admissions with severe sepsis in adult, general critical care units in England, Wales and Northern Ireland Admissions with severe sepsis in adult, general critical care units in England, Wales and Northern Ireland Question For all admissions to adult, general critical care units in the Case Mix Programme Database

More information

Looking for sepsis. Sepsis: Update. Prevalence of High Profile Dzs. Screening and risk stratification. Mortality of High Profile Diseases

Looking for sepsis. Sepsis: Update. Prevalence of High Profile Dzs. Screening and risk stratification. Mortality of High Profile Diseases Sepsis: Update Prevalence of High Profile Dzs Edward A. Panacek, MD, MPH Professor and Chair, Emergency Medicine USA Medical Center, Mobile, AL NDAFP Conference Big Sky. 2016 Syllabus Angus Crit Care Med

More information

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive

More information

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage

More information

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand 2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand Jack Perkins, MD FACEP, FAAEM, FACP Assistant Professor of Emergency and Internal Medicine Virginia Tech Carilion School of Medicine Why

More information

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Steven Q Simpson, MD, FCCP, FACP Professor of Medicine Division of Pulmonary and Critical Care University of Kansas Disclosures No

More information

Full Disclosure. The case for why it matters. Goal-directed Fluid Resuscitation

Full Disclosure. The case for why it matters. Goal-directed Fluid Resuscitation Goal-directed Fluid Resuscitation Christopher G. Choukalas, MD, MS Department of Anesthesia and Perioperative Care University of California, San Francisco I own no stocks Full Disclosure The case for why

More information

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D. Update in Sepsis Bill Janssen, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Conflicts of Interest: None A 62 year-old female presents to the ED with fever,

More information

Evaluation of Serum Lactate as Predictor of Morbidity and Mortality in Sepsis and Trauma Cases

Evaluation of Serum Lactate as Predictor of Morbidity and Mortality in Sepsis and Trauma Cases IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-38, p-issn:2319-7676. Volume 12, Issue 3 Ver. VII (May June 217), PP 1-5 www.iosrjournals.org Evaluation of Serum Lactate as Predictor

More information

Albumina nel paziente critico. Savona 18 aprile 2007

Albumina nel paziente critico. Savona 18 aprile 2007 Albumina nel paziente critico Savona 18 aprile 2007 What Is Unique About Critical Care RCTs patients eligibility is primarily defined by location of care in the ICU rather than by the presence of a specific

More information

Update in Critical Care Medicine

Update in Critical Care Medicine Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update

More information

Saving Lives: Focusing on Severe Sepsis and Septic Shock

Saving Lives: Focusing on Severe Sepsis and Septic Shock Saving Lives: Focusing on Severe Sepsis and Septic Shock Deborah Cameron, RN, CPHQ Paul Pratt, RN Glenn Russ, RN Providence Little Company of Mary Medical Center San Pedro January 18, 2011 Objectives 1.

More information

Statistical Analysis Plan

Statistical Analysis Plan The BALANCED Anaesthesia Study A prospective, randomised clinical trial of two levels of anaesthetic depth on patient outcome after major surgery Protocol Amendment Date: November 2012 Statistical Analysis

More information

Blood transfusions in sepsis, the elderly and patients with TBI

Blood transfusions in sepsis, the elderly and patients with TBI Blood transfusions in sepsis, the elderly and patients with TBI Shabbir Alekar MICU, CH Baragwanath Academic Hospital & The University of the Witwatersrand CCSSA Congress 11 June 2015 Packed RBC - complications

More information

Fluid bolus of 20% Albumin in post-cardiac surgical patient: a prospective observational study of effect duration

Fluid bolus of 20% Albumin in post-cardiac surgical patient: a prospective observational study of effect duration Fluid bolus of 20% Albumin in post-cardiac surgical patient: a prospective observational study of effect duration Investigators: Salvatore Cutuli, Eduardo Osawa, Rinaldo Bellomo Affiliations: 1. Department

More information

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the

More information

Impact of Fluids in Children with Acute Lung Injury

Impact of Fluids in Children with Acute Lung Injury Impact of Fluids in Children with Acute Lung Injury Canadian Critical Care Forum Toronto, Canada October 27 th, 2015 Adrienne G. Randolph, MD, MSc Critical Care Division, Department of Anesthesia, Perioperative

More information

Surviving Sepsis Campaign

Surviving Sepsis Campaign Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview By professor Ahmad Alaysh BMC-MICU 1 Surviving Sepsis A global program to Reduce mortality rates in severe

More information

Goal Directed Therapy

Goal Directed Therapy Goal Directed Therapy Dr Maurizio Cecconi MD FRCA FFICM MD(Res) Consultant and Reader Anaesthesia and Intensive Care Medicine St George s University Hospital NHS Foundation Trust St George s University

More information